THERAPEUTIC DRUG MONITORING IN PEDIATRIC HEART TRANSPLANT PATIENTS RECEIVING MYCOPHENOLATE MOFETIL.

被引：0
|
作者：
Plumage, E. F. [1 ]
Illamola, S. M. [1 ]
Balch, A. H. [1 ]
Sherwin, C. M. [1 ]
机构：
[1] Univ Utah, Salt Lake City, UT USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-126
引用
收藏
页码：S47 / S47
页数：1
相关论文
共 50 条
  • [31] Clinical outcome of heart transplant recipients receiving tacrolimus with or without mycophenolate mofetil
    Fuchs, U
    Tenderich, G
    Zittermann, A
    Szabados, F
    Minami, K
    Koerfer, R
    CLINICAL TRANSPLANTATION, 2006, 20 (04) : 450 - 456
  • [32] Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus
    Djabarouti, Sarah
    Duffau, Pierre
    Lazaro, Estibaliz
    Chapouly, Candice
    Greib, Carine
    Viallard, Jean-Francois
    Pellegrin, Jean-Luc
    Saux, Marie-Claude
    Breilh, Dominique
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (05) : 689 - 699
  • [33] Therapeutic drug monitoring of mycophenolate mofetil for the treatment of pediatric lupus nephritis: A cross-sectional study
    Kirubakaran, Navamani
    Punnen, Anu
    Prabha, Ratna
    Agarwal, Indira
    Kumar, Sathish
    INDIAN JOURNAL OF RHEUMATOLOGY, 2022, 17 (02) : 124 - 128
  • [34] Kidney Transplant Recipients with Diabetic Mellitus Demand Larger Doses of Mycophenolate Mofetil.
    Takamoto, D.
    Sasaki, H.
    Harada, S.
    Takada, Y.
    Harada, H.
    Tsujimoto, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 1088 - 1088
  • [35] Pharmacokinetic monitoring of mycophenolate mofetil in de novo kidney-transplant patients receiving belatacept or cyclosporine A
    Kamar, Nassim
    Ribes, David
    Lavit, Michel
    Esposito, Laure
    Lavayssiere, Laurence
    Cointault, Olivier
    Salvin, Sylvie
    Durand, Dominique
    Rostaing, Lionel
    TRANSPLANT INTERNATIONAL, 2007, 20 : 118 - 118
  • [36] Mizoribine revealed a synergic effect with cyclosporine in mice heart transplant model, and that was much stronger than mycophenolate mofetil.
    Fukami, N
    Kusaka, M
    Higuchi, T
    Sasaki, H
    Ishikawa, K
    Shiroki, R
    Hoshinaga, K
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 196 - 196
  • [37] Therapeutic Drug Monitoring of Cyclosporine in Heart Transplant Patients
    Sahnoun, D.
    Charfi, R.
    Guettari, M.
    Ziadi, J.
    Ouali, S.
    Taamallah, K.
    Ben Sassi, M.
    Gaies, E.
    Ben-Hammamia, S.
    El Jebari, H.
    Salouage, I
    Daghfous, R.
    Trabelsi, S.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S146 - S146
  • [38] The usefulness of therapeutic drug monitoring of mycophenolate mofetil: A computer simulation.
    van Hest, RM
    van Gelder, T
    Vulto, AG
    Mathot, RAA
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 233 - 233
  • [39] Predicting the feasibility of therapeutic drug monitoring of mycophenolate mofetil:: a computer simulation
    van Hest, RM
    van Gelder, T
    Vulto, AG
    Mathôt, RAA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (05) : 619 - 620
  • [40] PHARMACOKINETICS OF MYCOPHENOLIC ACID IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS RECEIVING ORAL MYCOPHENOLATE MOFETIL
    Jacobs, Bart
    Cornelissen, Marlies
    Aarnoutse, Rob
    Schreuder, Michiel
    Bruggemann, Roger
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (05) : 829 - 829
12345